Quality of Life of Postmenopausal Women in the ATAC (“Arimidex”, Tamoxifen, Alone or in Combination) Trial after Completion of 5 years' Adjuvant Treatment for Early Breast Cancer

Overview of attention for article published in Breast Cancer Research and Treatment, June 2006

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

policy: 2 policy sources
patent: 1 patent

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 211 Dimensions

Readers on

mendeley: 134 Mendeley

Summary Policy documents Patents Wikipedia Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Aromatashämmande läkemedel vid behandling av postmenopausala kvinnor med tidig ER-positiv bröstcancer

Cited by Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) on 26 Feb 2014

SBU is an independent national authority, tasked by the government with assessing health care and social service interventions from a broad perspective, covering medical, economic, ethical and social aspects.

Mammakarzinom der Frau; Diagnostik, Therapie und Nachsorge: Evidenzbericht: Synopse evidenzbasierter Leitlinien-Empfehlungen zur Diagnostik, Therapie und Nachsorge des Mammakarzinoms

Cited by The Association of the Scientific Medical Societies in Germany on 07 Feb 2012

The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.